MANHASSET, N.Y.–(BUSINESS WIRE)–Patients with metastatic uveal melanoma (UM), an aggressive eye cancer, often face a survival rate of less than two years once the disease spreads. While established treatment options are limited, to help patients livi…
Category: News
Gene Therapy Delivers Sustained Retinal Protection
People with age-related macular degeneration maintain vision and cut their need for supplemental injections by 90% 5 years after receiving gene therapy. Medscape Medical News
Samsung Epis Holdings Reports Second Quarter and Half-Year 2026 Financial Results
INCHEON, Korea–(BUSINESS WIRE)– #biosimilars–Samsung Epis Holdings announced its financial results for the second quarter and first half of fiscal year 2026.
Faricimab Reduces Shots, Improves Vision for Retinal Disease
In two studies in retinal disease, faricimab shows improved vision and a reduced injection burden in people who switched from first-generation drugs. Medscape Medical News
Delays Harmless for Most Macular Degeneration Patients
Waiting for prior authorization of drugs affects a small portion of patients with age-related macular degeneration, resulting in vision loss. Medscape Medical News
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufacturing Partnership
TOKYO & COLUMBUS, Ohio–(BUSINESS WIRE)–Restore Vision, Inc. (“Restore Vision”), a clinical-stage biotechnology company advancing gene therapies for retinal disorders, and Forge Biologics (“Forge”), a leading manufacturer of gene therapies and member …
Faricimab May Aid Hard-to-Treat Macular Degeneration Cases
Faricimab may stabilize vision, reduce retinal fluid and thickness, and cut treatment burden in difficult-to-treat cases of wet age-related macular degeneration. Medscape Medical News
Radiology Partners Strengthens RP Clinical Services Leadership with Matt Peterson as President and Krishna Nallamshetty, MD, as Chief Operating Officer
NASHVILLE, Tenn.–(BUSINESS WIRE)–Radiology Partners, Inc. (RP), through RP Clinical Services and its affiliated practices, today announced two leadership appointments, effective July 20. Matt Peterson has been named President of RP Clinical Services,…
Home Eye Scans Best Suited for High-Cost Retina Meds
Home-based optical tomography may only be cost-effective for patients on more expensive treatments. Medscape Medical News
Pott’s Puffy Tumor in Teen Leads to Bilateral Blindness
A teen with Pott’s puffy tumor develops irreversible bilateral blindness after delayed diagnosis and intracranial complications, highlighting the importance of its early recognition. Medscape Global
Nonvalved Drainage Device Benefits Kids With Glaucoma
In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years. Medscape Medical News
STAAR Surgical Announces Preliminary Net Sales for Second Quarter 2026
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced strong preliminary net sales for the se…
Riassunto: Compvide™ annuncia una collaborazione strategica con OpZira™ per velocizzare la crescita e lo sviluppo della piattaforma CIMED™
SEATTLE–(BUSINESS WIRE)–Compvide, Inc., il pioniere biotech dell’intelligence dei complementi funzionali tramite la diagnostica innovativa e il monitoraggio della risposta immunitaria, oggi ha dato il via a una collaborazione strategica con OpZira, I…
Compvide™ annonce un partenariat stratégique avec OpZira™ pour accélérer sa croissance et renforcer la plateforme CIMED™
SEATTLE–(BUSINESS WIRE)–Compvide, Inc., société de biotechnologie pionnière dans le domaine de l’intelligence fonctionnelle du système du complément grâce à des outils diagnostiques innovants et au suivi de la réponse immunitaire, a annoncé aujourd’h…
Compvide™ gibt strategische Zusammenarbeit mit OpZira™ bekannt zwecks Wachstum und Förderung der CIMED™ -Plattform
SEATTLE–(BUSINESS WIRE)–Compvide Inc., ein Biotechnologieunternehmen, das durch innovative Diagnostik und die Überwachung von Immunreaktionen Pionierarbeit im Bereich der funktionellen Komplement-Intelligenz leistet, gab heute eine strategische Zusam…
Samenvatting: Compvide™ kondigt strategische samenwerking met OpZira™ aan om de groei te versnellen en het CIMED™-platform verder te ontwikkelen
SEATTLE–(BUSINESS WIRE)–Compvide, Inc., een biotechnologiebedrijf dat baanbrekend werk verricht op het gebied van functionele complementintelligentie door middel van innovatieve diagnostiek en monitoring van immuunreacties, heeft vandaag een strategi…
Resumen: Compvide™ anuncia una colaboración estratégica con OpZira™ para acelerar el crecimiento y desarrollar la plataforma CIMED™
SEATTLE–(BUSINESS WIRE)–Compvide, Inc., una empresa de biotecnología pionera en el campo de la inteligencia del complemento funcional mediante diagnósticos innovadores y la monitorización de la respuesta inmunitaria, ha anunciado hoy una colaboración…
ASRS 2026
Read clinically focused news coverage of key developments from ASRS 2026. Medscape Internal Medicine
Closing Your Practice? Don’t Overlook These Legal Issues
Healthcare attorney Ericka Adler outlines what physicians need to know about patient notification, medical records, malpractice coverage, and practice closure. Medscape Business of Medicine
EZContacts Takes On Overpriced Luxury Eyewear With Vesari, Its First In-House Brand
RIDGEFIELD PARK, N.J.–(BUSINESS WIRE)–EZContacts takes on luxury eyewear markups with Vesari. Runway-inspired frames at one honest price: $95, prescription lenses included.